IPX — Impax Asset Management Income Statement
0.000.00%
Last trade - 00:00
- £505.86m
- £433.66m
- £178.37m
- 92
- 62
- 33
- 69
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 73.7 | 87.5 | 143 | 175 | 178 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 54.9 | 69.9 | 95.6 | 110 | 124 |
Operating Profit | 18.8 | 17.6 | 47.4 | 65.2 | 54.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 18.9 | 16.7 | 45.7 | 72.6 | 52.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15.9 | 13.7 | 40.2 | 59.5 | 39.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 15.9 | 13.7 | 40.2 | 59.5 | 39.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 15.9 | 13.7 | 40.2 | 59.5 | 39.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.128 | 0.109 | 0.303 | 0.447 | 0.298 |
Dividends per Share |